INTRODUCTION
Selenoproteins contain the rare amino acid Sec (selenocysteine) which is co-translationally inserted into protein in response to UGA codons (reviewed in [1] ). The human genome contains 25 genes encoding selenoproteins, such as GPxs (glutathione peroxidases), TXNRDs (thioredoxin reductases) and deiodinases [2] . Many selenoproteins are involved in protection from oxidative stress and have been implicated in protection from carcinogenesis [1] . tRNA [Ser] Sec UCA is initially charged with Ser (serine), which is converted into Sec on the tRNA. It is essential for selenoprotein expression and Figure 1 (A) highlights its specific features. At 90 nucleotides, it is the longest tRNA in mammals, and contains a few modified bases, e.g. 55 , m 1 A
58
(1-methyladenosine-58), and i 6 A 37 (N 6 -isopentenyl-adenosine-37), and was the first mammalian tRNA shown to contain mcm 5 U 34 (5-methoxycarbonylmethyluridine-34) and mcm 5 Um
34
(5-methylaminomethyl-2-thiouridine-34) [1] . Bioavailability of selenium is reflected by the ratio of the two tRNA [Ser] Sec isoforms containing mcm 5 U and mcm 5 Um at the wobble position [1] . Moreover, mcm 5 Um formation correlates with expression of stress-related selenoproteins such as GPx1, SEPT (selenoprotein T) and SEPR (selenoprotein R). The same selenoproteins also require i 6 A 37 , because mutation of tRNA [Ser] Sec to G 37 abolishes their expression [3] [4] [5] . Expression of selenoproteins is highest with full modification of tRNA [Ser] Sec containing 55 , m 1 A 58 , mcm 5 Um and i 6 A 37 . Incubation with lovastatin reduced i 6 A modification of tRNA [Ser] Sec and selenoprotein expression in cell culture [6] . Overexpression of 37A>G tRNA [Ser] Sec in mice not only reduced selenoprotein expression, but also accelerated prostate carcinogenesis [7, 8] .
The enzyme responsible for tRNA isopentenylation is encoded by the miaA gene in Escherichia coli, MOD5 in Saccharomyces cerevisiae and tit1 + in Schizosaccharomyces pombe. It was identified as a dimethylallyl pyrophosphate:tRNA transferase [IPT ( 2 -isopentenyl transferase); Figure 1B ] [9] [10] [11] [12] [13] . The i 6 A modification is found in many bacterial and eukaryotic tRNAs that read codons starting with U. Plants do not have i 6 A and archaea usually carry m 1 G 37 instead. tRNA carrying the i 6 A modification bind the ribosome more strongly and form a minihelix with the codon more efficiently, possibly because the modification disrupts competing interactions of bases within the anticodon loop of tRNA [14, 15] . Despite IPT homology and the fact that most tRNA sequences are known, prediction of which tRNA is a substrate of a given IPT is not yet possible [16] . All enzymes responsible for tRNA [Ser] Sec modification in the anticodon loop are still unknown. We speculated that TRIT1 is the IPT for tRNA [Ser] Sec and thus modulates selenoprotein expression. We tested this hypothesis in cell culture and in vitro using recombinant Trit1 and in vitro transcribed tRNA [Ser] Sec .
MATERIALS AND METHODS

Cultured cells and treatments
NIH 3T3 knockdown cells were grown at 37 • C, 5 % CO 2 in DMEM (Dulbecco's modified Eagle's medium) supplemented with 10 % FBS (fetal bovine serum) and 200 μg/ml hygromycin B (Invitrogen). HepG2-overexpressing and -knockdown cells were grown at 37
• C, 5 % CO 2 in DMEM/Ham's F12 supplemented with 10 % FBS and 2 μg/ml puromycin. Cells were seeded and treated with sodium selenite (Na 2 SeO 3 ) in FBS-free medium at the concentrations given in the Figures for 24 h or 3 days for NIH 3T3 and HepG2 cells respectively.
Knockdown and overexpression of Trit1
NIH 3T3 cells were transfected and stably selected (500 μg/ml hygromycin B) with three different Trit1 shRNA (small hairpin Abbreviations used: 2D, two-dimensional; DMAPP, dimethylallyl pyrophosphate; DMEM, Dulbecco's modified Eagle's medium; FBS, fetal bovine serum; GPx, glutathione peroxidase; i 6 A, N 6 -isopentenyl adenosine; IPT, 2 -isopentenyl tRNA transferase; m 1 A 58 , 1-methyladenosine-58; mcm 5 U, 5-methoxycarbonylmethyluridine; mcm 5 Um, 5-methylaminomethyl-2-thiouridine; pi 6 A, phospho-i 6 A; qPCR, quantitative PCR; Sec, selenocysteine; SEPP, selenoprotein P; Ser, serine; shRNA, small hairpin RNA; TXNRD, thioredoxin reductase; SEPS, selenoprotein S; TCA, trichloroacetic acid. 1 To whom correspondence should be addressed (email ulrich.schweizer@uni-bonn.de) RNA) constructs and the corresponding non-specific control as described in [17] . Sequences are given in Table 1 . After analysing the cell pools for Trit1 expression, selection of different clones was performed from the pool which showed the lowest expression of Trit1. Analysis of Trit1 mRNA levels was performed by RT (reverse transcription)-PCR (results not shown). One knockdown was chosen as that which showed the lowest Trit1 expression in mRNA and protein levels compared with the non-specific sequence. TRIT1 was amplified from HepG2 cDNA with primers given in Table 1 and cloned into the pGEM T-Easy vector (Promega). After sequence verification, TRIT1 was subcloned into pcDNA3 (Invitrogen). This construct was subsequently used as a template for cloning V5-and His-tagged TRIT1 into the pCDH-CMV-MCS-EF1-GreenPuro plasmid (System Biosciences). The primers used included NheI and EcoRI restriction sites respectively, and V5 and His tags were added using the reverse primers given in Table 1 . Plasmids containing shRNA sequences against TRIT1 were obtained from LFGC (Laboratory for Functional Genomic Research; Charité-Universitätsmedizin, Berlin, Germany) (catalogue numbers V2LHS_18767 and V2LHS_18771). HEK (human embryonic kidney)-293T cells were co-transfected with the corresponding target and packing plasmids as follows: 12.2 μg of psPAX2, 7.3 μg of pMD2.G and 17.6 μg of the TRIT1 overexpression, empty plasmid, non-specific or respective shRNA plasmid, using Lipofectamine TM 2000 (Invitrogen) following the manufacturer's recommendations. After 48 h, virus particles were harvested and used to transduce HepG2 cells. After selection with 5 μg/ml puromycin, protein expression was analysed by Western blotting.
Western blotting and protein precipitation
Protein extracts (50 μg) were resolved by SDS/PAGE (12 % gels), transferred on to nitrocellulose membranes and subjected to immunoblotting with rabbit polyclonal anti-GPx1 (Abcam; 1:1000 dilution), anti-GPx4 (Abcam; 1:1000 dilution), antiTrit1 (Sigma; 1:1000 dilution), anti-SEPS (selenoprotein S; Sigma-Aldrich; 1:1000 dilution) and anti-SEPP (selenoprotein P; Immunoglobe; 1:400 dilution) antibodies; and our sheep polyclonal anti-SEPP antibody (1:500 dilution). Monoclonal anti-TXNRD1 (Abcam; 1:1000 dilution) and anti-V5 (Invitrogen; 1:5000 dilution) antibodies were also used. Membranes were -TGCAGAATTCGGGTTTAAACTCAATGGTGATGGTG-ATGATGACCGGTACGCGTAGAATCGAGACCGAG-GAGAGGGTTAGGGATAGGCTTACCTTCGAACCGC-GGGCCCTCTAGACTCGAGCGGCCGCCACTGTGC-TGGATATCTGCAGAATTGCCCTTAACGCTGCATTT-CAGCTCTTGATC-3  qPCR  Trit1 fwd  5 -AGAGATATGCCCGGAAACAG-3  Trit1 rev  5 -CTCCTCCCACTTGGAAACAT-3  TRIT1 fwd  5 -ATACGGAAGAAGGTGGTGGT-3  TRIT1 rev  5 -TCTAGAACTGCCTGGTCAGC-3 reprobed with mouse monoclonal anti-β-actin antibody (Sigma; 1:25 000 dilution). In order to detect the secreted SEPP to the cell medium, total protein was precipitated from 1 ml of medium using TCA (trichloroacetic acid). Protein pellets were dissolved in lysis buffer and used as mentioned aboved.
qPCR (quantitative PCR)
Analysis was performed with SYBR Green on iCycler (Bio-Rad Laboratories) using primers given in Table 1 and normalized to GAPDH (glyceraldehyde 3-phosphate dehydrogenase).
Recombinant expression of Trit1
Trit1 was expressed as a C-terminally 10×His-tagged fusion. The D55G and T32A Trit1 mutants were generated using a site-directed mutagenesis kit. [Ser]Sec transcripts were treated with or without 2 μg of Trit1 in a 100 μl reaction volume containing 50 mM Tris/HCl, pH 7.5, 5 mM MgCl 2 , 1 mM dithiothreitol and 2 mM DMAPP. Following a 2 h incubation at 37
• C, reaction mixtures were heated at 65
• C for 10 min, extracted using phenol/chloroform/isoamyl alcohol (125:24:1 by vol., pH 4.5) and tRNA was precipitated with 0.1 vol. of 3 M ammonium acetate and 3 vol. of ethanol. tRNA was collected by centrifugation, washed with 70 % ethanol and dissolved in 25 μl of water. tRNAs were digested overnight with nuclease P1 (Sigma) in 50 mM ammonium acetate, pH 5.3, at 37
• C, concentrated by SpeedVac, dissolved in 5 μl of water and spotted on to a cellulose TLC plate (20 cm×20 cm, CEL 300 DEAE, Macherey + Nagel). The resulting 5 -monophosphate nucleosides were resolved by 2D (two-dimensional)-TLC as described in [19] . TLC plates were dried and exposed to a PhosphorImager. The mobility rate of each base was compared with those of known modified bases [19] [20] [21] .
Statistical analysis
Overexpression and knockdown experiments were performed in triplicate and all experiments were repeated at least twice. Statistical analyses were performed using GraphPad Prism software. Data are depicted as means + − S.D.
RESULTS AND DISCUSSION
Knockdown of Trit1 reduces selenoprotein expression
We knocked down Trit1 protein expression in NIH 3T3 cells by stable expression of shRNA (Figure 2A) . Analysis of mRNA abundance confirmed reduced Trit1 expression ( Figure 2B ). GPx1 expression is highly sensitive to tRNA [Ser] Sec modification as demonstrated in mouse liver expressing only tRNA [Ser] Sec carrying a 37A>G substitution [5] . Accordingly, we found that GPx1 levels in murine NIH 3T3 cells expressing the Trit1-knockdown construct were significantly reduced compared with control cells ( Figure 2C ).
We then asked whether selenoprotein expression also depends on TRIT1 in human cells. We transduced and stably selected HepG2 cells with human V5-tagged TRIT1 or two TRIT1 shRNAs (KD7 and KD8). qPCR confirmed moderate knockdown and overexpression of TRIT1 ( Figures 3A and 3B) . Western blotting for TRIT1 protein confirmed reduction of endogenous TRIT1 ( Figure 3C ). TRIT1 protein levels did not depend on selenium availability in the medium ( Figure 3D ).
We then assessed selenoprotein expression in HepG2 cells expressing the TRIT1-knockdown construct. Expression of TXNRD1, GPx4 and SEPS was reduced in both KD7 and KD8 cells, but only in the absence of additional selenium ( Figure 3E ). Secretion of SEPP into the medium was not reduced under lowselenium conditions. A moderate reduction is not unexpected considering the fundamental role of i 6 A 37 in decoding UCN Ser codons by tRNA Ser IGA and respective selective pressure in cell culture. Although TXNRD1 activity has also been found to be reduced in 37A>G tRNA [Ser] Sec -overexpressing CHO (Chinesehamster ovary) cells, TXNRD1 was efficiently expressed in hepatocytes of transgenic mice expressing exclusively 37A>G tRNA
[Ser]Sec [5] .
Overexpression of TRIT1 does not increase selenoprotein expression
Overexpression of TRIT1 massively increased TRIT1 protein levels, but did not change protein abundance of cellular TXNRD1, GPx4, SEPS or secreted SEPP in the cell culture medium, irrespective of the availability of selenium in the medium (Figure 4 ). This finding is probably explained by the observation that normal mature tRNA populations are saturated with i 6 A modifications [9] . Overexpression of the modifying enzyme thus cannot increase isopentenylation of tRNA [Ser] Sec further.
Recombinant Trit1 isopentenylates tRNA [Ser]Sec at A 37
We expressed His-tagged murine Trit1 in E. coli, purified the enzyme by Ni 2 + affinity chromatography, and performed 
Figure 4 Overexpression of TRIT1 does not increase selenoprotein expression in HepG2 cells
The amounts of selenoproteins are not changed irrespective of the amount of selenium in the medium. β-Actin was used as a loading control. SEPP was precipitated from medium. OE, overexpressed. Figure 5A ). tRNA [Ser] Sec from E. coli also carries the i 6 A 37 modification [22] . To exclude co-purification of undetected traces of endogenous MiaA, we expressed two mutant variants of Trit1 and compared these with wild-type enzyme in the tRNA [Ser] Sec -isopentenylation assay. We chose to mutate Thr 32 and Asp 55 , because both amino acids are conserved in MiaA and MOD5p and site-directed mutagenesis in miaA significantly inhibited catalytic activity [23] . This is rationalized by their positions in the active centres of both enzymes, where the corresponding threonine residue activates the DMAPP moiety, whereas the corresponding aspartate engages in hydrogen bonds with N 6 of A 37 and thus positions the acceptor amino group [24, 25] . Trit1 proteins carrying the D55G or T32A mutations exhibited significantly reduced specific activity of 50 % and 10 % of wild-type respectively ( Figure 5B) .
We then prepared 32 P-labelled tRNA [Ser] Sec by in vitro transcription in the presence of [α-
32 P]ATP. In vitro isopentenylation with DMAPP was followed by precipitation of high-molecular-mass tRNA, enzymatic hydrolysis with ribonuclease P1, and separation of 5 -32 P-labelled adenosines by TLC. As expected, incubation with Trit1 and DMAPP produced a minor fraction of [ 32 P]pi 6 A (phospho-i 6 A; Figure 5C ). Finally, we found that substitution of guanine for A 37 in in vitro transcribed tRNA [Ser] Sec completely abolished the formation of [ 32 P]pi 6 A, demonstrating that A 37 is the only adenosine modified by Trit1 in tRNA
[Ser]Sec . We did not attempt to further characterize Trit1 as a DMAPP:tRNA transferase using other tRNAs as substrates, because there is a consensus that Trit1 is the mammalian homologue of MiaA, MOD5p and Tit1p [16] . Yeast are devoid of selenoproteins, but do express mod5-dependent phenotypes associated with nonsense suppression or stress-response, potentially regulated through MOD5 prion formation [16, 26] . Interestingly, the other highly modified base position in tRNA [Ser] Sec is U 34 . It carries the mcm 5 U modification, which depends on tRNA methyltransferase TRM9/ABH8. Reduced activity of this enzyme in yeast or human cells mediates translational control of a class of stress-response genes characterized by skewed codon usage [27, 28] . This is reminiscent of the dependence of many selenoprotein genes that are called 'stress-responsive' and are sensitive to mutations in tRNA [Ser] Sec affecting bases 37 and 34 [5] . The human TRM9/ABH8 homologue probably involved in the mcm 5 U modification at the wobble base of tRNA [Ser] Sec is often lost in colorectal carcinoma [29] .
Selenium levels and selenoprotein expression have been implicated in cancer risk [1, 7] . Interestingly, TRIT1 has been found as a tumour suppressor gene in A549 lung cancer cells and is down-regulated and lost in cancer-promoting changes in tumorigenicity [30] . However, we are not aware of follow-up studies on selenoprotein expression in A549 lung cancer cells that show that this effect relies on selenoprotein expression. Other studies have shown that reducing selenoprotein expression can enhance tumour formation [7] . Given the fact that TRIT1 has other substrates beyond tRNA [Ser] Sec , however, other potential mechanisms may as well contribute to translational control of gene expression, e.g. frameshifting or nonsense suppression. Finally, MOD5p, and probably also Trit1, may act on mitochondrial tRNAs, thereby profoundly affecting cellular physiology [13, 30] . Recently, a second prenyl modification of tRNA was discovered. The well-known mnm 5 s 2 U (5-methoxycarbonylmethyl-2 -Omethyluridine) modified base at position 34 was shown to be further modified by geranylation leading to the highly modified base mnm 5 ges 2 U (5-methylaminomethyl-2-geranylthiouridine) [31] . It is intriguing that SelU, the enzyme responsible for geranylation of s 2 U derivatives, is also able to exchange the sulfur for selenium [31] .
AUTHOR CONTRIBUTION
Noelia Fradejas, Bradley Carlson, Eddy Rijntjes, Niels-Peter Becker and Ryuta Tobe planned and performed the experiments, and analysed the data. Ulrich Schweizer analysed the data and wrote the paper. Noelia Fradejas, Bradley Carlson, Niels-Peter Becker and Ryuta Tobe participated in writing the paper. Ulrich Schweizer designed the study and planned the experiments.
